You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-06-05
Court	District Court, D. Delaware	Date Terminated	2018-08-23
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	6,017,927
Link to Docket	External link to docket

Small Molecule Drugs cited in Astellas Pharma Inc. v. Cipla Limited

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Details for Astellas Pharma Inc. v. Cipla Limited (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2018-06-05	1	Complaint	an action for patent infringement of United States Patent No. 6,017,927 (“the ’927 patent”), arising under…BACKGROUND A. The ’927 Patent 15. The United States Patent and Trademark Office duly and…correct copy of the ’927 patent is attached as Exhibit A. 16. The ’927 patent claims, inter alia…927 patent. 22. AICL and APEL are exclusive licensees of rights under the ’927 patent. …x27;927 Patent. 35. On information and belief, Cipla was aware of the ‘927 patent and its	External link to document
2018-08-23	14	Order	relating to United States Patent No. 6,017,927 ("the ' 927 patent"); WHEREAS…IV certification with respect to the '927 patent to a Paragraph III certification pursuant to which…which it agrees that the '927 patent, plus any other exclusivity, will expire before the requested…earlier than the expiration date of the '927 patent, including any extensions and/or additional periods…III certification with respect to the '927 patent, the parties have resolved this action;	External link to document
2018-08-27	15	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (Attachments: # 1 …2018 23 August 2018 1:18-cv-00844 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-05	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,017,927. (sar) (Entered: 06…2018 23 August 2018 1:18-cv-00844 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.